USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases

NCT00622973 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Bladder Cancer

Interventions

OTHER: Imaging: diffusion-weighted MRI
OTHER: Sinerem (USPIO) enhanced MRI

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

[object Object]